Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma.
Wang Z, Zheng Y, Park HJ, Li J, Carr JR, Chen YJ, Kiefer MM, Kopanja D, Bagchi S, Tyner AL, Raychaudhuri P.
Wang Z, et al. Among authors: chen yj.
Mol Cancer Ther. 2013 May;12(5):759-67. doi: 10.1158/1535-7163.MCT-12-0903. Epub 2013 Feb 20.
Mol Cancer Ther. 2013.
PMID: 23427295
Free PMC article.